SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-027607
Filing Date
2021-05-13
Accepted
2021-05-13 16:39:05
Documents
75
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q atha-10q_20210331.htm   iXBRL 10-Q 2745739
2 EX-31.1 atha-ex311_190.htm EX-31.1 16268
3 EX-31.2 atha-ex312_189.htm EX-31.2 16172
4 EX-32.1 atha-ex321_188.htm EX-32.1 8269
5 EX-32.2 atha-ex322_187.htm EX-32.2 8311
6 GRAPHIC gaqqfo0qsrm3000001.jpg GRAPHIC 35121
  Complete submission text file 0001564590-21-027607.txt   9717438

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA atha-20210331.xsd EX-101.SCH 63433
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atha-20210331_cal.xml EX-101.CAL 43336
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atha-20210331_def.xml EX-101.DEF 196715
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE atha-20210331_lab.xml EX-101.LAB 460026
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atha-20210331_pre.xml EX-101.PRE 349151
12 EXTRACTED XBRL INSTANCE DOCUMENT atha-10q_20210331_htm.xml XML 1964922
Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Filer) CIK: 0001620463 (see all company filings)

IRS No.: 453368487 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39503 | Film No.: 21920249
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences